期刊文献+

Paradoxical reduction of cerebral blood flow after acetazolamide loading:a hemodynamic and metabolic study with ^(15)O PET 被引量:3

Paradoxical reduction of cerebral blood flow after acetazolamide loading:a hemodynamic and metabolic study with ^(15)O PET
原文传递
导出
摘要 Paradoxical reduction of cerebral blood flow (CBF) after administration of the vasodilator acetazolamide is the most severe stage of cerebrovascular reactivity failure and is often associated with an increased oxygen extraction fraction (OEF). In this study, we aimed to reveal the mechanism underlying this phenomenon by focusing on the ratio of CBF to cerebral blood volume (CBV) as a marker of regional cerebral perfusion pressure (CPP). In 37 patients with unilateral internal carotid or middle cerebral arterial (MCA) steno-occlusive disease and 8 normal controls, the baseline CBF (CBFb), CBV, OEF, cerebral oxygen metabolic rate (CMRO2), and CBF after acetazolamide loading in the anterior and posterior MCA territories were measured by (15)~O positron emission tomography. Paradoxical CBF reduction was found in 28 of 74 regions (18 of 37 patients) in the ipsilateral hemisphere. High CBFb (〉47.6 mL/100 mL/min, n = 7) was associated with normal CBFb/CBV, increased CBV, decreased OEF, and normal CMRO2. Low CBFb (〈31.8 mL/100 mL/min, n = 9) was associated with decreased CBFb/CBV, increased CBV, increased OEF, and decreased CMRO2. These findings demonstrated that paradoxical CBF reduction is not always associated with reduction of CPP, but partly includes high- CBFb regions with normal CPP, which has not been described in previous studies. Paradoxical reduction of cerebral blood flow (CBF) after administration of the vasodilator acetazolamide is the most severe stage of cerebrovascular reactivity failure and is often associated with an increased oxygen extraction fraction (OEF). In this study, we aimed to reveal the mechanism underlying this phenomenon by focusing on the ratio of CBF to cerebral blood volume (CBV) as a marker of regional cerebral perfusion pressure (CPP). In 37 patients with unilateral internal carotid or middle cerebral arterial (MCA) steno-occlusive disease and 8 normal controls, the baseline CBF (CBFb), CBV, OEF, cerebral oxygen metabolic rate (CMRO2), and CBF after acetazolamide loading in the anterior and posterior MCA territories were measured by (15)~O positron emission tomography. Paradoxical CBF reduction was found in 28 of 74 regions (18 of 37 patients) in the ipsilateral hemisphere. High CBFb (〉47.6 mL/100 mL/min, n = 7) was associated with normal CBFb/CBV, increased CBV, decreased OEF, and normal CMRO2. Low CBFb (〈31.8 mL/100 mL/min, n = 9) was associated with decreased CBFb/CBV, increased CBV, increased OEF, and decreased CMRO2. These findings demonstrated that paradoxical CBF reduction is not always associated with reduction of CPP, but partly includes high- CBFb regions with normal CPP, which has not been described in previous studies.
出处 《Neuroscience Bulletin》 SCIE CAS CSCD 2014年第5期845-856,共12页 神经科学通报(英文版)
基金 partly supported by the Molecular Imaging Program, a grant(21591561) from the Ministry of Education,Culture,Sports, Science,and Technology and the Japan Science and Technology Agency,Japan the Research Promotion Program on Health from the National Institute of Biomedical Innovation,Japan a Grant-in-Aid(H21-019 and H21-5) from the Ministry of Health, Welfare,and Labour,Japan
关键词 ACETAZOLAMIDE cerebral blood flowparadoxical reduction positron emission tomographyvasodilatation acetazolamide cerebral blood flowparadoxical reduction positron emission tomographyvasodilatation
  • 相关文献

参考文献38

  • 1Symon L. Experimental evidence for "intracerebral steal" following CO2 inhalation. Scand J Clin Lab Invest Supp11968, 102: XIlI:A.
  • 2Symon L, Pasztor E, Branston NM. The distribution and density of reduced cerebral blood flow following acute middle cerebral artery occlusion: an experimental study by the technique of hydrogen clearance in baboons. Stroke 1974, 5: 355-364.
  • 3Regli F, Yamaguchi T, Waltz AG. Effects of acetazolamide on cerebral ischemia and infarction after experimental occlusion of middle cerebral artery. Stroke 1971, 2: 456-460.
  • 4Vorstrup S, Henriksen L, Paulson OB. Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J Clin Invest 1984, 74: 1634-1639.
  • 5Vorstrup S, Brun B, Lassen NA. Evaluation of the cerebral vasodilatory capacity by the acetazolamide test before ECIC bypass surgery in patients with occlusion of the internal carotid artery. Stroke 1986,17: 1291-1298.
  • 6Vorstrup S. Tomographic cerebral blood flow measurements in patients with ischemic cerebrovascular disease and evaluation of the vasodilatory capacity by the acetazolamide test. Acta Neurol Scand Supp11988, 114: 1-48.
  • 7Kuwabara Y, Ichiya Y, Sasaki M, Yoshida T, Masuda K. Time dependency of the acetazolamide effect on cerebral hemodynamics in patients with chronic occlusive cerebral arteries. Early steal phenomenon demonstrated by [150]H20 positron emission tomography. Stroke 1995, 26: 1825-1829.
  • 8Okazawa H, Yamauchi H, Toyoda H, Sugimoto K, Fujibayashi Y, Yonekura Y. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease. J Nucl Med 2003, 44: 1875-1883.
  • 9Baron JC, Bousser MG, Rey A, Guillard A, Comar D, Castaigne P. Reversal of focal "misery-perfusion syndrome" by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 150 positron emission tomography. Stroke 1981, 12: 454-459.
  • 10Gibbs JM, Wise RJ, Leenders KL, Jones T. Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet 1984,1: 310-314.

同被引文献33

  • 1Shortt Conor P,Gleeson Tadhg G,Breen Karen A,McHugh John,O’Connell Martin J,O’Gorman Peter J,Eustace Stephen J.Whole-Body MRI versus PET in assessment of multiple myeloma disease activity. AJR. American journal of roentgenology . 2009
  • 2Jennings M,Marcu LG,Bezak E.PET-specific parameters and radiotracers in theoretical tumour modelling. Comput Math Methods Med . 2015
  • 3FDA Drug Safety Communication.FDA evaluating the risk of brain deposits with repeated use of gadolinium-based contrast agents for magnetic resonance imaging (MRI). http://www.fda.gov/Drugs/Drug Safety/ucm455386.htm .
  • 4In Lee,Yoo Jin,Sung Hong,Seoung-Oh Yang.??Musculoskeletal Applications of PET/MR(J)Semin Musculoskelet Radiol . 2014 (02)
  • 5Disselhorst, Jonathan A,Bezrukov, Ilja,Kolb, Armin,Parl, Christoph,Pichler, Bernd J.??Principles of PET/MR Imaging(J)The Journal of Nuclear Medicine . 2014
  • 6Tadashi Watabe,Eku Shimosegawa,Hiroki Kato,Kayako Isohashi,Mana Ishibashi,Mitsuaki Tatsumi,Kazuo Kitagawa,Toshiyuki Fujinaka,Toshiki Yoshimine,Jun Hatazawa.??SSJD14101300036876(J)Neuroscience Bulletin . 2014 (5)
  • 7Franz Wolfgang Hirsch,Bernhard Sattler,Ina Sorge,Lars Kurch,Adrian Viehweger,Lutz Ritter,Peter Werner,Thies Jochimsen,Henryk Barthel,Uta Bierbach,Holger Till,Osama Sabri,Regine Kluge.??PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner(J)Pediatric Radiology . 2013 (7)
  • 8Fahey, Frederic H,Treves, S Ted,Adelstein, S James.??Minimizing and Communicating Radiation Risk in Pediatric Nuclear Medicine*(J)EN . 2012 (1)
  • 9Chieh Lin,Emmanuel Itti,Alain Luciani,Benhalima Zegai,Shih-jui Lin,Frédérique Kuhnowski,Frédéric Pigneur,Isabelle Gaillard,Gaetano Paone,Michel Meignan,Corinne Haioun,Alain Rahmouni.??Whole-Body Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Treatment Response Assessment in Patients With Diffuse Large B-Cell Lymphoma: Pilot Study(J)Investigative Radiology . 2011 (5)
  • 10Partovi S,Kohan AA,Zipp L,Faulhaber P,Kosmas C,Ros PR,Robbin MR.Hybrid PET/MR imaging in two sarcoma patientsclinical benefits and implications for future trials. Int J Clin Exp Med . 2014

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部